泌尿系统感染生物标志物研究进展

doi:10.3969/j.issn.1673-8640.2020.02.019

检验医学 ›› 2020, Vol. 35 ›› Issue (2): 178-180.DOI: 10.3969/j.issn.1673-8640.2020.02.019

泌尿系统感染生物标志物研究进展

杨美玲¹, 刘浩², 杨林¹, 朱平¹()

1. 三峡大学第一临床医学院肾内科,湖北宜昌 443002
2. 三峡大学医学院,湖北宜昌 443002

收稿日期:2018-09-26 出版日期:2020-02-29 发布日期:2020-03-22
作者简介:null
作者简介:杨美玲,女,1993年生,硕士,主要从事泌尿系统感染机制研究。
基金资助:
湖北省教育厅资助项目（B2017024）

Research progress on the biomarkers of urinary tract infection

YANG Meiling¹, LIU Hao², YANG Lin¹, ZHU Ping¹()

1. Department of Nephrology,the First Clinical Hospital of China Three Gores University,Yichang 443002,Hubei,China
2. China Three Gores University School of Medicine,Yichang 443002,Hubei,China

Received:2018-09-26 Online:2020-02-29 Published:2020-03-22

摘要/Abstract

摘要：

泌尿系统感染（UTI）是临床最常见的细菌感染之一,通常症状不典型。准确诊断和早期治疗对于防止继发血流感染及改善患者长期预后至关重要。目前,主要通过临床症状结合实验室检查结果对UTI进行诊断。实验室检测中,中段尿培养是UTI诊断的金标准,但其阳性检出率低且耗时长,无法满足临床需要。因此,寻找新的UTI生物标志物作为中段尿培养方法的补充,具有重要的临床意义。文章就目前几种新的血清和尿液UTI生物标志物进行综述。

关键词: 泌尿系统感染, 生物标志物, 血清, 尿液

Abstract:

Urinary tract infection（UTI） is one of the most common bacterial infections. Because UTI is usually characterized by atypical symptoms,accurate diagnosis and early treatment are important for preventing septicemia and improving long-term prognosis. The current diagnosis of UTI is based on clinical symptoms combined with clinical laboratory determinations. Urinary culturing is the gold standard for the diagnosis of UTI,and it has the disadvantages of low positive determination rate and time-consuming,which is unable to meet clinical needs. Therefore,finding new biomarkers of UTI is of clinical significance. Several potential biomarkers of serum and urine are reviewed.

Key words: Urinary tract infection, Biomarker, Serum, Urine

中图分类号:

R446.1

杨美玲, 刘浩, 杨林, 朱平. 泌尿系统感染生物标志物研究进展[J]. 检验医学, 2020, 35(2): 178-180.

YANG Meiling, LIU Hao, YANG Lin, ZHU Ping. Research progress on the biomarkers of urinary tract infection[J]. Laboratory Medicine, 2020, 35(2): 178-180.

参考文献 20

[1]	王鑫,崔向丽,杨辉,等. 肾移植术后尿路感染病原菌及抗感染治疗方案分析[J]. 中国医院药学杂志,2017,37(12):1195-1199.
[2]	XU R Y,LIU H W,LIU J L,et al.Procalcitonin and C-reactive protein in urinary tract infection diagnosis[J]. BMC Urol,2014,14:45.
[3]	LEVINE A R,TRAN M,SHEPHERD J,et al.Utility of initial procalcitonin values to predict urinary tract infection[J]. Am J Emerg Med,2018,36(11):1993-1997.
[4]	FISHER J,LINDER A.Heparin-binding protein:a key player in the pathophysiology of organ dysfunction in sepsis[J]. J Intern Med,2017,281(6):562-574.
[5]	LIU X W,MA T,LIU W,et al.Sustained increase in angiopoietin-2,heparin-binding protein,and procalcitonin is associated with severe sepsis[J]. J Crit Care,2018,45:14-19.
[6]	LINDER A,JOHANSSON L,THULIN P,et al.Erysipelas caused by group A streptococcus activates the contact system and induces the release of heparin-binding protein[J]. J Invest Dermatol,2010,130(5):1365-1372.
[7]	KJÖLVMARK C,AKESSON P,LINDER A. Elevated urine levels of heparin-binding protein in children with urinary tract infection[J]. Pediatric Nephrol,2012,27(8):1301-1318.
[8]	KJÖLVMARK C,PAHLMAN L I,AKESSON P,et al. Heparin-binding protein:a diagnostic biomarker of urinary tract infection in adults[J]. Open Forum Infect Dis,2014,1(1):ofu004.
[9]	CIRAGIL P,KURUTAS E B,MIRALOGLU M.New markers:urine xanthine oxidase and myeloperoxidase in the early detection of urinary tract infection[J]. Dis Markers,2014,2014:269362.
[10]	MASAJTIS-ZAGAJEWSKA A,NOWICKI M.New markers of urinary tract infection[J]. Clin Chim Acta,2017,471:286-291.
[11]	EHSANIPOUR F,NOORBAKHSH S,ZARABI V,et al.Comparison the serum STREM1 levels between children with upper and lower UTI[J]. Curr Pediat Rev,2017,13(2):152-156.
[12]	SIERRA-DIAZ E,BRAVO CUÉLLAR A,ORTIZ LAZARENO P C,et al. Urine TREM-1 as a marker of urinary tract infection in children[J]. J Int Med Res,2017,45(2):631-638.
[13]	FLENKER K S,BURGHARDT E L,DUTTA N,et al.Rapid detection of urinary tract infections via bacterial nuclease activity[J]. Mol Ther,2017,25(6):1353-1362.
[14]	VALDIMARSSON S,JODAL U,BARREGARD L,et al.Urine neutrophil gelatinase-associated lipocalin and other biomarkers in infants with urinary tract infection and in febrile controls[J]. Pediatr Nephrol,2017,32(11):2079-2087.
[15]	PRICE J R,GURAN L,LIM J Y,et al.Neutrophil gelatinase-associated lipocalin biomarker and urinary tract infections:a diagnostic case-control study(NUTI study)[J]. Female Pelvic Med Reconstr Surg,2017,23(2):101-107.
[16]	LUBELL T R,BARASCH J M,XU K,et al.Urinary neutrophil gelatinase-associated lipocalin for the diagnosis of urinary tract infections[J]. Pediatrics,2017,140(6):e20171090.
[17]	FORSTER C S,JOHNSON K,PATEL V,et al.Urinary NGAL deficiency in recurrent urinary tract infections[J]. Pediatr Nephrol,2017,32(6):1077-1080.
[18]	JUNG N,BYUN H J,PARK J H,et al.Diagnostic accuracy of urinary biomarkers in infants younger than 3 months with urinary tract infection[J]. Korean J Pediatr,2018,61(1):24-29.
[19]	KIM H H,CHUNG M H,BIN J H,et al.Urinary YKL-40 as a candidate biomarker for febrile urinary tract infection in young children[J]. Ann Laboratory Med,2018,38(1):39-45.
[20]	STALENHOEF J E,VAN NIEUWKOOP C,WILSON D C,et al.Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection[J]. J Infect,2018,77(1):18-24.

泌尿系统感染生物标志物研究进展

Research progress on the biomarkers of urinary tract infection

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 20

相关文章 15

编辑推荐

Metrics

[1]	孙泽朋, 王洪彬, 王建东, 宋德伟, 肖鹏. 心肌损伤多肽和蛋白类标志物方法学分析和进展[J]. 检验医学, 2023, 38(8): 784-789.
[2]	张敏, 王彬宇, 迟伟群, 刘禹. 外泌体非编码RNA作为疾病诊断生物标志物的研究进展[J]. 检验医学, 2023, 38(6): 594-598.
[3]	刘庆阳, 袁建明, 夏进军, 姜风英, 王秋波, 王晓明. 基于GEO数据库和临床样本验证CXCL9作为类风湿关节炎生物标志物的研究[J]. 检验医学, 2023, 38(12): 1121-1129.
[4]	周福荣, 李龑杼, 刘勇敢. lncRNA SNP在结直肠癌易感性预测和预后评估中的应用[J]. 检验医学, 2023, 38(12): 1206-1210.
[5]	邓晨, 戴家泽, 邱丽红, 沈威廷, 蔡木发, 罗文英. 湛江地区高毒力肺炎克雷伯菌分子流行特征[J]. 检验医学, 2023, 38(11): 1026-1031.
[6]	王刚强, 刁艳君, 何娟, 杨若凡, 闫宏斌, 汪沛, 卢佩, 李程华, 肖凤静, 郑善銮, 郝晓柯, 程翔, 刘家云. 尿液分析自动审核规则的建立、验证和临床应用[J]. 检验医学, 2023, 38(10): 957-966.
[7]	鲁启源, 卢建华. 人工关节假体周围感染诊断生物标志物研究进展[J]. 检验医学, 2023, 38(10): 997-1002.
[8]	黄媛, 陈锋, 毛镭篥, 张陵林, 吕倩, 闫军, 崔巍. 基于MALDI-TOF MS的血清多肽组学在胰腺良恶性疾病鉴别诊断中的应用[J]. 检验医学, 2023, 38(1): 1-7.
[9]	胡韶华, 陈黎, 赵梦, 马展, 张泓. 上海地区儿童肺炎支原体感染流行病学特征分析[J]. 检验医学, 2023, 38(1): 14-17.
[10]	陈雪薇, 李一荣. 基于GEO数据库筛选代谢综合征潜在生物标志物[J]. 检验医学, 2023, 38(1): 32-38.
[11]	吴亚婷, 李卓林, 雷艳, 贾如雪, 张胜行, 王水良. 尿液中miRNA作为常见恶性肿瘤生物标志物研究进展[J]. 检验医学, 2023, 38(1): 94-99.
[12]	张濛, 李莎, 常艳丽, 王鲁, 徐建军, 张青云. 血管内皮生长因子在黑色素瘤疗效监测和预后判断中的价值[J]. 检验医学, 2022, 37(9): 821-825.
[13]	韩静贤, 庞丽, 王勇. 多发性硬化患者血清和脑脊液IL-33的表达及其临床意义[J]. 检验医学, 2022, 37(9): 844-846.
[14]	王芮, 李朝燕, 赵爱光. 循环肿瘤DNA检测在胃癌诊疗中的应用现状[J]. 检验医学, 2022, 37(9): 877-881.
[15]	罗国菊, 金晶, 徐佳, 郝英英, 汪晓巍, 郭野. UF-5000全自动尿液分析仪健康成人全参数参考区间分析[J]. 检验医学, 2022, 37(8): 751-753.